100 related articles for article (PubMed ID: 27816666)
1. Reduced serum level of leukocyte cell-derived chemotaxin 2 is associated with the presence of diabetic retinopathy.
Okumura A; Unoki-Kubota H; Yoshida-Hata N; Yamamoto-Honda R; Yamashita S; Iwata M; Tobe K; Kajio H; Noda M; Katai N; Yamagoe S; Kaburagi Y
Clin Chim Acta; 2016 Dec; 463():145-149. PubMed ID: 27816666
[TBL] [Abstract][Full Text] [Related]
2. [Changes of plasma endothelin-1 and vascular endothelial growth factor in diabetic retinopathy and the clinical application value thereof].
Zhu H; Shi CH
Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(40):2837-9. PubMed ID: 18167288
[TBL] [Abstract][Full Text] [Related]
3. Increased serum leukocyte cell-derived chemotaxin 2 (LECT2) levels in obesity and fatty liver.
Okumura A; Unoki-Kubota H; Matsushita Y; Shiga T; Moriyoshi Y; Yamagoe S; Kaburagi Y
Biosci Trends; 2013 Dec; 7(6):276-83. PubMed ID: 24390366
[TBL] [Abstract][Full Text] [Related]
4. Circulating LECT2 levels in newly diagnosed type 2 diabetes mellitus and their association with metabolic parameters: An observational study.
Zhang Z; Zeng H; Lin J; Hu Y; Yang R; Sun J; Chen R; Chen H
Medicine (Baltimore); 2018 Apr; 97(15):e0354. PubMed ID: 29642178
[TBL] [Abstract][Full Text] [Related]
5. Visceral fat area is a strong predictor of leukocyte cell-derived chemotaxin 2, a potential biomarker of dyslipidemia.
Tanisawa K; Taniguchi H; Sun X; Ito T; Kawakami R; Sakamoto S; Higuchi M
PLoS One; 2017; 12(3):e0173310. PubMed ID: 28278265
[TBL] [Abstract][Full Text] [Related]
6. Elevated serum levels of leukocyte cell-derived chemotaxin 2 are associated with the prevalence of metabolic syndrome.
Zheng X; Lu J; Xiang S; Zou P; Chen H; Liu J; Zeng C; He Y
Acta Diabetol; 2024 May; 61(5):643-655. PubMed ID: 38383671
[TBL] [Abstract][Full Text] [Related]
7. Serum leukocyte cell-derived chemotaxin 2 level is associated with atopic dermatitis patients.
Zhao K; Xu F; Jiang X; Chen J; Zhu X; Zhou Q; Xu S
Ann Palliat Med; 2021 Oct; 10(10):11006-11012. PubMed ID: 34763463
[TBL] [Abstract][Full Text] [Related]
8. Increased Serum Chemerin Levels in Diabetic Retinopathy of Type 2 Diabetic Patients.
Du J; Li R; Xu L; Ma R; Liu J; Cheng J; Zhang Z; Sun H
Curr Eye Res; 2016; 41(1):114-20. PubMed ID: 25848840
[TBL] [Abstract][Full Text] [Related]
9. Circulating Concentrations of Insulin Resistance-Associated Hepatokines, Selenoprotein P and Leukocyte Cell-Derived Chemotaxin 2, during an Oral Glucose Tolerance Test in Humans.
Mohri K; Misu H; Takayama H; Ishii KA; Kikuchi A; Lan F; Enyama Y; Takeshita Y; Saito Y; Kaneko S; Takamura T
Biol Pharm Bull; 2019 Mar; 42(3):373-378. PubMed ID: 30606895
[TBL] [Abstract][Full Text] [Related]
10. Low blood and vitreal BDNF, LXA4 and altered Th1/Th2 cytokine balance are potential risk factors for diabetic retinopathy.
Kaviarasan K; Jithu M; Arif Mulla M; Sharma T; Sivasankar S; Das UN; Angayarkanni N
Metabolism; 2015 Sep; 64(9):958-66. PubMed ID: 26004392
[TBL] [Abstract][Full Text] [Related]
11. LECT2 Ameliorates Blood-Retinal Barrier Impairment Secondary to Diabetes Via Activation of the Tie2/Akt/mTOR Signaling Pathway.
Qin YJ; Xiao K; Zhong Z; Zhao Y; Yu T; Sun XF
Invest Ophthalmol Vis Sci; 2022 Mar; 63(3):7. PubMed ID: 35262733
[TBL] [Abstract][Full Text] [Related]
12. Serum Leukocyte Cell-Derived Chemotaxin 2 (LECT2) Level Is Associated with Osteoporosis.
Wang Q; Xu F; Chen J; Xie YQ; Xu SL; He WM
Lab Med; 2023 Jan; 54(1):106-111. PubMed ID: 35976970
[TBL] [Abstract][Full Text] [Related]
13. Serum vascular adhesion protein-1 correlates with vascular endothelial growth factor in patients with type II diabetes.
Yoshikawa N; Noda K; Shinoda H; Uchida A; Ozawa Y; Tsubota K; Mashima Y; Ishida S
J Diabetes Complications; 2013; 27(2):162-6. PubMed ID: 23062326
[TBL] [Abstract][Full Text] [Related]
14. Association of leukocyte cell-derived chemotaxin 2 (LECT2) with NAFLD, metabolic syndrome, and atherosclerosis.
Yoo HJ; Hwang SY; Choi JH; Lee HJ; Chung HS; Seo JA; Kim SG; Kim NH; Baik SH; Choi DS; Choi KM
PLoS One; 2017; 12(4):e0174717. PubMed ID: 28376109
[TBL] [Abstract][Full Text] [Related]
15. Circulating Serum Fatty Acid-Binding Protein 4 Levels Predict the Development of Diabetic Retinopathy in Type 2 Diabetic Patients.
Zhang XZ; Tu WJ; Wang H; Zhao Q; Liu Q; Sun L; Yu L
Am J Ophthalmol; 2018 Mar; 187():71-79. PubMed ID: 29305311
[TBL] [Abstract][Full Text] [Related]
16. Cytokine profile of peripheral blood in type 2 diabetes mellitus patients with diabetic retinopathy.
Lee JH; Lee W; Kwon OH; Kim JH; Kwon OW; Kim KH; Lim JB
Ann Clin Lab Sci; 2008; 38(4):361-7. PubMed ID: 18988929
[TBL] [Abstract][Full Text] [Related]
17. Association of serum adiponectin with diabetic microvascular complications among south Indian type 2 diabetic subjects - (CURES-133).
Pradeepa R; Surendar J; Indulekha K; Chella S; Anjana RM; Mohan V
Clin Biochem; 2015 Jan; 48(1-2):33-8. PubMed ID: 25445230
[TBL] [Abstract][Full Text] [Related]
18. Association Of Serum Total Bilirubin Level With Diabetic Retinopathy In Type 2 Diabetes Mellitus.
Ghaffar T; Marwat ZI; Ullah F; Khan S; Hassan Aamir AU
J Ayub Med Coll Abbottabad; 2016; 28(3):537-541. PubMed ID: 28712230
[TBL] [Abstract][Full Text] [Related]
19. [Role of vascular endothelial growth factor in the development of diabetic retinopathy in patients with type 1 diabetes mellitus].
Ermakova NA; Syrodeeva ON; Antsiferov MB; Balatskaia NV; Krasnova LB
Vestn Oftalmol; 2008; 124(1):25-8. PubMed ID: 18318205
[TBL] [Abstract][Full Text] [Related]
20. Serum and Vitreous Pentraxin 3 Concentrations in Patients with Diabetic Retinopathy.
Zhou W; Hu W
Genet Test Mol Biomarkers; 2016 Mar; 20(3):149-53. PubMed ID: 26836044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
